Effect of Liraglutide on Blood Pressure: a Meta-Analysis of Liraglutide Randomized Controlled Trials
doi: 10.1016/j.ebiom.2019.11.051 50 HanX.GuoJ.YinM.LiuY.YouY.ZhanJ.et al
I LOVE the pink lemonade greens from BEAM
KEY TAKEAWAYS GLP-1 medications require individualized medical evaluation, not one-size-fits-all prescribing Direct-to-consumer microdosing platforms lack FDA approval and proper medical oversight The erosion of trust in healthcare has created opportunities for unregulated treatments Comprehensive metabolic care includes regular lab work, body composition monitoring, and personalized treatment plans Technology should enhance medical care, not replace proper physician evaluation NOTABLE QUOTE "I see so many people that come in, you know, they're obsessed with monitoring their HRV, their heart rate variability, and yet they had no idea they have pre-diabetes and they had no idea that they have triglyceride levels through the roof." Dr
They did not validate every use promoted online or establish standardized FDA-approved dosing, safety, or effectiveness for those substances
